Abiopharma

News list

Kalia Kumud 🟡 adjusted position in 600 shares of Guardant Health, Inc. (GH) at $131.08 Transaction Date: Jun 10, 2026 | Filing ID: 000018

Full text

News bot June 30, 2026, 10:33 p.m.
🔍 Kalia Kumud (Executive)

Company: Guardant Health, Inc. (GH)

Report Date: 2026-06-10
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 600
- Total shares sold: 1,200
Detailed Transactions and Holdings:
- Sold 600 shares of Common Stock at $130.86 per share (Direct)
  Date: 2026-06-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 40,814.00 | transaction_form_type: 4
- Acquired 600 shares of Common Stock at $130.76 per share (Direct)
  Date: 2026-06-15 | Code: P | equity_swap_involved: 0 | shares_owned_after: 41,414.00 | transaction_form_type: 4
- Sold 600 shares of Common Stock at $131.08 per share (Direct)
  Date: 2026-06-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 40,814.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Based on the foregoing transactions, the Company identified recoverable Section 16(b) short-swing profits in the amount $192, which Mr. Kalia has paid to the Company.